Nov 6, 2025, 10:06 AM by User Not Found

Bio-IT World | Antibody-drug conjugates (ADCs) are among the most promising and complex therapeutics in modern oncology. The global ADC market is growing at an extraordinary pace. Yet, this promise comes with complexity. Multi-step conjugations, long processing times, highly potent raw materials, and stringent quality requirements pose significant manufacturing challenges.

Nov 6, 2025, 07:55 AM by

Nov 6, 2025, 07:55 AM by

Nov 5, 2025, 01:00 AM by User Not Found

Bio-IT World | For millions of patients prescribed drugs with a narrow therapeutic window, safe dosing depends on therapeutic drug monitoring. But outside of hospital labs equipped with specialized machines and trained staff, monitoring drug concentrations in real time has been largely out of reach. DNA nanotechnology may hold the key to bringing this critical capability to the point of care—and even into patients’ homes.

Nov 4, 2025, 08:47 AM by

Partnership with Solve Scientific strengthens international sales as part of ongoing global expansion

Nov 4, 2025, 08:47 AM by

DoseMe, a global leader in model-informed precision dosing (MIPD) software and a portfolio company of Fairlong Capital, today announced the acquisition of Firstline, a leading clinical decision support platform utilized worldwide. Firstline enables clinicians to rapidly access local, evidence-based infectious disease treatment guidance, susceptibility patterns, and antimicrobial stewardship (AMS) resources. The combination of DoseMe and Firstline creates a single, connected experience from therapy selection through personalized dosing, giving clinicians a faster path to optimal care.

Nov 4, 2025, 08:46 AM by

Nov 4, 2025, 01:01 AM by User Not Found

Bio-IT World | Pacific Biosciences announced a chemistry upgrade and SMRT cell reuse capability last month at the American Society of Human Genetics (ASHG) meeting. CEO Christian Henry said the moves targeted dramatic price reductions for customers and to compete with short-read sequencing.

Nov 3, 2025, 08:52 AM by

Lonza has announced that it has signed an agreement to acquire Redberry.

Nov 3, 2025, 08:52 AM by

Aylward Enterprises, a recognized leader in oral solid dose (OSD) packaging automation, highlights the TCM Tablet Counter, engineered to provide 100% count verification and reject-on-the-fly performance for pharmaceutical, nutraceutical, and healthcare packaging lines.

Oct 30, 2025, 08:36 AM by

EazeBio has announced a strategic partnership with the University of California, Santa Cruz to advance and commercialize a groundbreaking instrument-free diagnostic platform.

Oct 30, 2025, 08:36 AM by

Oct 30, 2025, 01:01 AM by User Not Found

Bio-IT World | NVIDIA CEO Jensen Huang used NVIDIA’s GTC 2025 keynote to share his vision for the convergence of quantum computing and artificial intelligence, while revealing staggering demand for the company’s next-generation Grace Blackwell architecture that signals a fundamental shift in how the world computes.

Oct 29, 2025, 05:36 AM by User Not Found

Bio-IT World | SandboxAQ releases AQCat25-EV2, a new quantitative AI model trained on the AQCat25 dataset; Illumina launches BioInsight, a new business within Illumina developed to meet industry demand for deeper biologic insights; Thermo Fisher Scientific introduces the Applied Biosystems SwiftArrayStudio Microarray Analyzer; and more.

Oct 28, 2025, 09:08 AM by

Spaarne Gasthuis, a top clinical teaching hospital serving part of the Greater Amsterdam region, is fully digitizing its pathology practice with Concentriq® AP-Dx* from Proscia®. With this software platform, the hospital will empower its pathologists to play an even more significant role in guiding personalized treatment decisions for hundreds of thousands of patients each year.

Oct 28, 2025, 01:00 AM by User Not Found

Bio-IT World | Kailera Therapeutics advances injectable dual GLP-1/GIP receptor agonist; Tubulis develops antibody-drug conjugate for ovarian cancer and lung adenocarcinomas; Trogenix advances their pipeline of potentially curative cancer therapies across multiple aggressive solid tumors into the clinic; and more.

Oct 24, 2025, 09:10 AM by

Leading Global Cancer Center to Integrate Triomics AI Platform to Improve Clinical Trial Screening

Oct 24, 2025, 09:10 AM by

Elixion Biotech has emerged from stealth with a breakthrough that could reshape early-stage drug discovery. In just eleven months, and without external funding, the Zurich-based therapeutics company has validated its quantum physics-informed R&D process, confirming its ability to accurately predict and identify novel drug targets. The milestone positions Elixion to advance its precision-oncology pipeline and opens the door to seed-stage investment.

Oct 24, 2025, 09:10 AM by

Oct 23, 2025, 08:15 AM by